Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer

Sustained HER2/HER3 signaling due to the overproduction of the HER3 ligand heregulin (HRG) is proposed as a key contributor to endocrine resistance in estrogen receptor-positive (ER+) breast cancer. The molecular mechanisms linking HER2 transactivation by HRG-bound HER3 to the acquisition of a hormo...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Mol Sci
Päätekijät: Papadimitropoulou, Adriana, Vellon, Luciano, Atlas, Ella, Steen, Travis Vander, Cuyàs, Elisabet, Verdura, Sara, Espinoza, Ingrid, Menendez, Javier A., Lupu, Ruth
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2020
Aiheet:
Brief Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7589856/
https://ncbi.nlm.nih.gov/pubmed/33086721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21207737
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia